Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non‐Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study
Journal of Magnetic Resonance Imaging · 2024
DOI: 10.1002/jmri.28723 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Hong-Kai Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Vascular Diseases, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Diabetes Mellitus, Type 2, Cardiomyopathies, Ventricular Dysfunction, Left. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Capital's Funds for Health Improvement and Research Foundation of China, National Key R&D Program of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Poorly controlled type 2 diabetes mellitus (T2DM) is known to result in left ventricular (LV) dysfunction, myocardial fibrosis, and ischemic/nonischemic dilated cardiomyopathy (ICM/NIDCM). However, less is known about the prognostic value of T2DM on LV longitudinal function and late gadolinium enhancement (LGE) assessed with cardiac MRI in ICM/NIDCM patients.
Purpose
To measure LV longitudinal function and myocardial scar in ICM/NIDCM patients with T2DM and to determine their prognostic values. Study Type Retrospective cohort. Population Two hundred thirty‐five ICM/NIDCM patients (158 with T2DM and 77 without T2DM). Field Strength/Sequence 3T; steady‐state free precession cine; phase‐sensitive inversion recovery segmented gradient echo LGE sequences. Assessment Global peak longitudinal systolic strain rate (GLPSSR) was evaluated to LV longitudinal function with feature tracking. The predictive value of GLPSSR was determined with ROC curve. Glycated hemoglobin (HbA1c) was measured. The primary adverse cardiovascular endpoint was follow up every 3 months. Statistical Tests Mann–Whitney U test or student's t ‐test; Intra and inter‐observer variabilities; Kaplan–Meier method; Cox proportional hazards analysis (threshold = 5%).
Results
ICM/NIDCM patients with T2DM exhibited significantly lower absolute value of GLPSSR (0.39 ± 0.14 vs. 0.49 ± 0.18) and higher proportion of LGE positive (+) despite similar LV ejection fraction, compared to without T2DM. LV GLPSSR was able to predict primary endpoint (AUC 0.73) and optimal cutoff point was 0.4. ICM/NIDCM patients with T2DM (GLPSSR < 0.4) had more markedly impaired survival. Importantly, this group (GLPSSR < 0.4, HbA1c ≥ 7.8%, or LGE (+)) exhibited the worst survival. In multivariate analysis, GLPSSR, HbA1c, and LGE (+) significantly predicted primary adverse cardiovascular endpoint in overall ICM/NIDCM and ICM/NIDCM patients with T2DM.
Conclusions
T2DM has an additive deleterious effect on LV longitudinal function and myocardial fibrosis in ICM/NIDCM patients. Combining GLPSSR, HbA1c, and LGE could be promising markers in predicting outcomes in ICM/NIDCM patients with T2DM. Evidence Level 3 Technical Efficacy 5
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung, and Vascular Diseases, Capital Medical University, Beijing, China.
- Department of Cardiology, Clinical Center for Coronary Heart Disease, Beijing Institute of Heart Lung and Blood Vessel Disease, Beijing Anzhen Hospital, Capital Medical University, Beijing, China.
- Department of Cardiac Surgery, Beijing Anzhen Hospital, Beijing Institute of Heart, Lung and Vascular Diseases, Capital Medical University, Beijing, China.
- Discipline of Medical Radiation Science, Curtin Medical School, Curtin University, Perth, Western Australia, Australia.
ORCID-Profile: Hong-Kai Zhang, Lei Xu
Förderung
- National Natural Science Foundation of China
- Capital's Funds for Health Improvement and Research Foundation of China
- National Key R&D Program of China
- National Key Research and Development Program of China
Zitieren
APA
Zhang, H. K., Du, Y., Shi, C. Y., Zhang, N., Gao, H. Q., Zhong, Y. L., Wang, M. Z., Zhou, Z., Gao, X. L., Li, S., Yang, L., Liu, T., Fan, Z. M., Sun, Z. H., & Xu, L. (2024). Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non‐Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.28723
Vancouver
Zhang HK, Du Y, Shi CY, Zhang N, Gao HQ, Zhong YL, et al. Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non‐Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.28723
BibTeX
@article{Zhang2024,
author = {Zhang, Hong-Kai and Du, Yu and Shi, Chun-Yan and Zhang, Nan and Gao, Hui-Qiang and Zhong, Yong-Liang and Wang, Mao-Zhou and Zhou, Zhen and Gao, Xue-Lian and Li, Shuang and Yang, Lin and Liu, Tong and Fan, Zhan-Ming and Sun, Zhong-Hua and Xu, Lei},
title = {Prognostic Value of Left Ventricular Longitudinal Function and Myocardial Fibrosis in Patients With Ischemic and Non‐Ischemic Dilated Cardiomyopathy Concomitant With Type 2 Diabetes Mellitus: A 3.0 T Cardiac MR Study},
journal = {Journal of Magnetic Resonance Imaging},
year = {2024},
doi = {10.1002/jmri.28723}
}
EUVIMED